About Avanos Medical Inc
Ticker
info
AVNS
Trading on
info
NYSE
ISIN
info
US05350V1061
Industry
info
Medical Devices
Sector
info
Healthcare
CEO
info
-
Headquarters
info
5405 Windward Parkway, Alpharetta, GA, United States, 30004
Employees
info
2,227
Website
info
https://avanos.com
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; OrthogenRx knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Metrics
BasicAdvanced
Market cap
info
$651M
P/E ratio
info
-
EPS
info
-$8.42
Dividend Yield
info
0.00%
Beta
info
1.17
Forward P/E ratio
info
0
EBIDTA
info
$90.3M
Ex dividend date
info
-
Price & volume
Market cap
info
$651M
Average daily volume
info
0.6M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0.95
Price to book
info
0.78
Earnings
EPS
info
-$8.42
EPS estimate (current quarter)
info
$0.40
EPS estimate (next quarter)
info
$0.32
EBITDA
info
$90.3M
Revenues (TTM)
info
$688M
Revenues per share (TTM)
info
$14.95
Technicals
Beta
info
1.17
52-week High
info
$25.36
52-week Low
info
$14.10
50-day moving average
info
$15.71
200-day moving average
info
$19.58
Short ratio
info
1.62
Short %
info
2.46%
Management effectiveness
ROE (TTM)
info
37.42%
ROA (TTM)
info
1.97%
Profit margin
info
57.01%
Gross profit margin
info
$381M
Operating margin
info
4.90%
Growth
Quarterly earnings growth (YoY)
info
37.50%
Quarterly revenue growth (YoY)
info
3.60%
Share stats
Outstanding Shares
info
46M
Float
info
41.9M
Insiders %
info
3.22%
Institutions %
info
95.97%
Analyst Insights & forecasts
info

34% Buy

66% Hold

0% Sell

Based on information from 3 analysts.

Average price target

info
$17.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$0.19
$0.21
9.52%
Q1 • 24Beat
$0.29
$0.29
-
Q2 • 24Beat
$0.36
$0.35
2.86%
Q3 • 24Beat
$0.43
$0.40
8.39%
Q4 • 24Beat
-
-
-
Q1 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$170M
$4.3M
2.52%
Q3 • 24
$180M
$-397M
221.21%
Q4 • 24
5.40%
9,339.53%
8,866.24%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$1.66B
$427M
25.75%
Q3 • 24
$1.15B
$326M
28.22%
Q4 • 24
30.31%
23.63%
9.58%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$23M
$-12M
$-16M
$20M
Q3 • 24
$57.9M
$-7.6M
$-27.4M
$53.1M
Q4 • 24
151.74%
36.67%
71.25%
165.50%
QoQ growth
QuarterlyAnnual
Sentiment analysis

-1.5

Neutral

+1.5

-0.19

Last 30 days

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Avanos Medical Inc share?
Collapse

Avanos Medical Inc shares are currently traded for undefined per share.

How many shares does Avanos Medical Inc have?
Collapse

Avanos Medical Inc currently has 46M shares.

Does Avanos Medical Inc pay dividends?
Collapse

No, Avanos Medical Inc doesn't pay dividends.

What is Avanos Medical Inc 52 week high?
Collapse

Avanos Medical Inc 52 week high is $25.36.

What is Avanos Medical Inc 52 week low?
Collapse

Avanos Medical Inc 52 week low is $14.10.

What is the 200-day moving average of Avanos Medical Inc?
Collapse

Avanos Medical Inc 200-day moving average is $19.58.

Who is Avanos Medical Inc CEO?
Collapse

The CEO of Avanos Medical Inc is -.

How many employees Avanos Medical Inc has?
Collapse

Avanos Medical Inc has 2,227 employees.

What is the market cap of Avanos Medical Inc?
Collapse

The market cap of Avanos Medical Inc is $651M.

What is the P/E of Avanos Medical Inc?
Collapse

The current P/E of Avanos Medical Inc is null.

What is the EPS of Avanos Medical Inc?
Collapse

The EPS of Avanos Medical Inc is -$8.42.

What is the PEG Ratio of Avanos Medical Inc?
Collapse

The PEG Ratio of Avanos Medical Inc is null.

What do analysts say about Avanos Medical Inc?
Collapse

According to the analysts Avanos Medical Inc is considered a hold.